Accutane Inflammatory Bowel Disease Lawsuit Results in Hung Jury

A New Jersey product liability trial over claims that the acne medication Accutane caused a teen to suffer inflammatory bowel disease (IBD) has resulted in a hung jury. 

The Accutane trial, which concluded last week, was brought by the parents of Priya Tanna, who was 15 when she started taking the Roche medication to treat her acne.

According to allegations raised at trial, Tanna developed inflammatory bowel disease (IBD) as a result of Accutane side effects.

Did You Know?

Millions of Philips CPAP Machines Recalled

Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.

Learn More

However, Roche argued at trial that there was a 7-step warning process in place before Tanna began taking Accutane. Therefore, the drug maker argued that they are not liable for the injuries suffered.

As deliberations approached the Christmas holiday weekend, a New Jersey state court jury failed to come to an agreement on the claims, resulting in a hung jury.

The case is one of about 6,000 Accutane lawsuits that are currently pending in New Jersey state court before Judge Carol E. Higbee. All of the complaints involve similar allegations that plaintiffs developed inflammatory bowel disease, ulcerative colitis, Crohn’s disease and other debilitating bowel injuries.

Accutane, known generically as isotretinoin, has been used by more than 16 million people worldwide since it was first introduced in the early 1980s as a treatment for severe acne.

Roche discontinued Accutane in June 2009 due to the increasing costs associated with the Accutane litigation, but a number of generic versions remain available under names such as Claravis, Sotret, Amnesteem and generic isotretinoin.

So far, plaintiffs have been successful in seven out of the first 10 Accutane bowel disease lawsuits that have been presented to a jury, with millions of dollars in damages from Accutane being awarded.

In April, a New Jersey jury awarded $2 million in compensation to a woman who developed ulcerative colitis from Accutane. However, the same jury declined to award damages to two other plaintiffs involved in the same trial.


"*" indicates required fields

Share Your Comments

I authorize the above comments be posted on this page*

Have Your Comments Reviewed by a Lawyer

Provide additional contact information if you want an attorney to review your comments and contact you about a potential case. This information will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Bard Argues Hernia Mesh Lawsuits Previously Selected for Bellwether Trials Are No Longer
Bard Argues Hernia Mesh Lawsuits Previously Selected for Bellwether Trials Are No Longer "Representative" (Posted 3 days ago)

Bard claims two cases selected for the third and fourth bellwether trials are no longer representative of the litigation due to the plaintiffs' worsening injuries and need for additional surgeries due to their failed hernia mesh products.